5 results about "Helenium" patented technology

L'OREAL The present invention relates to methods for obtaining a plant extract from flowering tops of Inula helenium, as well as plant extracts of Inula helenium, compositions comprising them, and their implementation to prevent and / or treat a pigmentary disorder, in particular (i) a pigmentary spot, in particular an actinic lentigo, (ii) a post-inflammatory hyperpigmentation, in particular linked to a scar or an unsightly disorder following an inflammatory skin manifestation, in particular a scar or an acne mark or (iii) a melasma.

The present invention relates to the field of pharmaceutical production, and discloses a preparation process of a new type of Liangxue Shiwei tablets. The prescription of the Liangxue Shiwei tablets is as follows: 89.3 g of Lithospermum erythrorhizon, 89.3 g of Gypsum Fibrosum (cool-processed), 35.7 g of Aucklandia lappa, 35.7 g of Picrorhiza scrophulariiflora, 53.6 g of Dianthus superbus, 35.7 g of Gypsum Fibrosum, 53.6 g of Carthamus tinctorius, 35.7 g of Glycyrrhiza uralensis, 35.7 g of Inula helenium, and 35.7 g of Glehnia littoralis. The preparation steps are as follows: S01 According to the prescription, the above 8 herbs including Lithospermum erythrorhizon, Gypsum Fibrosum (cool-processed), Aucklandia lappa, Picrorhiza scrophulariiflora, Dianthus superbus, Gypsum Fibrosum, Carthamus tinctorius, and Inula helenium, and the other 2 herbs including Glehnia littoralis and Glycyrrhiza uralensis are jointly pulverized into fine powder, screened, and mixed evenly for standby; S02 Granulate the fine powder of the drugs evenly mixed in the above S01 through an adhesive, press into tablets, coat the tablets, and the drying temperature is 20-70 °C for 2-6 hours; the adhesive is one or more of the water decoction of the 2 herbs including Glehnia littoralis and Glycyrrhiza uralensis, 1%-10% sodium carboxymethylcellulose solution, and 5%-20% polyvinylpyrrolidone k30 solution. This new process increases the binding effect of granulation, finally improves the tablet quality of the Liangxue Shiwei tablets, ensures the qualified rate of first-class products, eliminates repetitive operations such as rework, and improves labor productivity.

The invention belongs to the technical field of acupuncture point patch preparation, and relates to a coronary heart storax pill volatile oil nano-liposome / PVA swelling type microneedle patch. Crushing storax, frankincense, sandalwood and elecampane, adding water for soaking, slightly boiling, condensing and refluxing; and drying to obtain the GXSHW-EO. Soybean lecithin, cholesterol, sodium cholate and GXSHW-EO are added into methyl alcohol and trichloromethane, a phosphoric acid buffer solution is added after rotary evaporation, ultrasonic treatment and filtering are conducted after rotary evaporation, and the microneedle patch is obtained after a PVA solution, a PVP solution and a citric acid solution are evenly mixed, subjected to centrifugal vacuum pouring, vacuumized, dried and demoulded. By integrating the targeting delivery advantage of the NLCs, the intelligent swelling characteristic of the PVA microneedle patch and the meridian regulation effect of acupoint stimulation, the triple synergistic effect of physical infiltration promotion, chemical drug release and biological response is achieved. The drug loading capacity and the stability of active ingredients of the traditional Chinese medicine are enhanced.

The application provides a traditional Chinese medicine composition for treating or improving pregnancy-induced hypertension, and relates to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine composition is prepared from traditional Chinese medicine raw materials of Gyrinopsys pentaphylla, Radix Rehmanniae Preparata, Apocynum venetum, Inula helenium, schreyberite, Dipsacus asper, Taxillus sutchuenensis, root of Boehmeria nivea, Fructus Amomi Rotundus and Perilla frutescens. The traditional Chinese medicine composition can significantly reduce the tail artery pressure, 24h urine protein and inflammatory factor level of a pregnancy-induced hypertension rat, significantly improve the adverse pregnancy outcome of a pregnant rat caused by hypertension, and has a significant treatment effect on a pregnancy-induced hypertension rat model. The traditional Chinese medicine composition is expected to become a new drug for treating pregnancy-induced hypertension.

The present invention relates to processes for obtaining a plant extract of flowering tops of Inula helenium, and also to Inula helenium plant extracts, to compositions comprising same, and to the uses thereof for preventing and / or treating a chronic inflammatory skin disorder, in particular a pigmentary disorder, in particular (i) a pigmentary spot, in particular an actinic lentigo, (ii) a post-inflammatory hyperpigmentation, in particular associated with a scar or with an unaesthetic disorder consecutive to an inflammatory skin manifestation, in particular a scar or an acne mark, a scar or a rosacea mark or (iii) melasma.